eDruginfo.com
Wolters Kluwer | Lippencott Williams & Wilkins
Drug Updates | New Indications

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Quik Tools

   Drug Info Links

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



esomeprazole
Nexium Pharmaceutical company:
AstraZeneca
www.purplepill.com

NEW INDICATION & DOSAGE
Treatment of gastroesophageal reflux disease (GERD) and healing of erosive esophagitis in children ages 1 to 11 years--
Children ages 1 to 11 years: For short-term treatment of symptomatic GERD--10 mg/day P.O. for up to 8 weeks; for healing of erosive esophagitis--in children weighing less than 20 kg (44 lb), 10 mg/day P.O. for up to 8 weeks; in children weighing 20 kg or more, 10 to 20 mg/day P.O. for up to 8 weeks.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins